• Je něco špatně v tomto záznamu ?

Skin inflammation and impaired adipogenesis in a mouse model of acid ceramidase deficiency

J. Rybova, L. Kuchar, J. Sikora, WM. McKillop, JA. Medin

. 2022 ; 45 (6) : 1175-1190. [pub] 20220919

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032852

Acid ceramidase catalyzes the degradation of ceramide into sphingosine and a free fatty acid. Acid ceramidase deficiency results in lipid accumulation in many tissues and leads to the development of Farber disease (FD). Typical manifestations of classical FD include formation of subcutaneous nodules and joint contractures as well as the development of a hoarse voice. Healthy skin depends on a unique lipid profile to form a barrier that confers protection from pathogens, prevents excessive water loss, and mediates cell-cell communication. Ceramides comprise ~50% of total epidermis lipids and regulate cutaneous homeostasis and inflammation. Abnormal skin development including visual skin lesions has been reported in FD patients, but a detailed study of FD skin has not been performed. We conducted a pathophysiological study of the skin in our mouse model of FD. We observed altered lipid composition in FD skin dominated by accumulation of all studied ceramide species and buildup of abnormal storage structures affecting mainly the dermis. A deficiency of acid ceramidase activity also led to the activation of inflammatory IL-6/JAK/signal transducer and activator of transcription 3 and noncanonical NF-κB signaling pathways. Last, we report reduced proliferation of FD mouse fibroblasts and adipose-derived stem/stromal cells (ASC) along with impaired differentiation of ASCs into mature adipocytes.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032852
003      
CZ-PrNML
005      
20230131151308.0
007      
ta
008      
230120s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jimd.12552 $2 doi
035    __
$a (PubMed)36083604
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Rybova, Jitka $u Departments of Pediatrics and Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA $1 https://orcid.org/000000024779638X
245    10
$a Skin inflammation and impaired adipogenesis in a mouse model of acid ceramidase deficiency / $c J. Rybova, L. Kuchar, J. Sikora, WM. McKillop, JA. Medin
520    9_
$a Acid ceramidase catalyzes the degradation of ceramide into sphingosine and a free fatty acid. Acid ceramidase deficiency results in lipid accumulation in many tissues and leads to the development of Farber disease (FD). Typical manifestations of classical FD include formation of subcutaneous nodules and joint contractures as well as the development of a hoarse voice. Healthy skin depends on a unique lipid profile to form a barrier that confers protection from pathogens, prevents excessive water loss, and mediates cell-cell communication. Ceramides comprise ~50% of total epidermis lipids and regulate cutaneous homeostasis and inflammation. Abnormal skin development including visual skin lesions has been reported in FD patients, but a detailed study of FD skin has not been performed. We conducted a pathophysiological study of the skin in our mouse model of FD. We observed altered lipid composition in FD skin dominated by accumulation of all studied ceramide species and buildup of abnormal storage structures affecting mainly the dermis. A deficiency of acid ceramidase activity also led to the activation of inflammatory IL-6/JAK/signal transducer and activator of transcription 3 and noncanonical NF-κB signaling pathways. Last, we report reduced proliferation of FD mouse fibroblasts and adipose-derived stem/stromal cells (ASC) along with impaired differentiation of ASCs into mature adipocytes.
650    _2
$a myši $7 D051379
650    _2
$a zvířata $7 D000818
650    12
$a Farberova nemoc $7 D055577
650    _2
$a kyselá ceramidasa $x genetika $7 D055573
650    _2
$a adipogeneze $7 D050156
650    _2
$a ceramidy $x metabolismus $7 D002518
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a zánět $7 D007249
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kuchar, Ladislav $u Rare Diseases Research Unit, Department of Pediatrics and Inherited Metabolic Disorders, Charles University, 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000307216624
700    1_
$a Sikora, Jakub $u Rare Diseases Research Unit, Department of Pediatrics and Inherited Metabolic Disorders, Charles University, 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic $u Institute of Pathology, Charles University, 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000341042023
700    1_
$a McKillop, William M $u Departments of Pediatrics and Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA $1 https://orcid.org/0000000196837339
700    1_
$a Medin, Jeffrey A $u Departments of Pediatrics and Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA $u Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA $1 https://orcid.org/0000000181658995
773    0_
$w MED00002747 $t Journal of inherited metabolic disease $x 1573-2665 $g Roč. 45, č. 6 (2022), s. 1175-1190
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36083604 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151304 $b ABA008
999    __
$a ok $b bmc $g 1891536 $s 1184187
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 45 $c 6 $d 1175-1190 $e 20220919 $i 1573-2665 $m Journal of inherited metabolic disease $n J Inherit Metab Dis $x MED00002747
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace